ArticleBiomaterials2026
Investigating the functional contributions of phospholipids in selective organ targeting lipid nanoparticles.
Article in Biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Targeted delivery of mRNA to immune cells forDrug delivery · 2026Review
- Overcoming hepatic tropism: Precision engineering of lipid nanoparticles for extrahepatic RNA delivery.Materials today. Bio · 2026Review
- From Morphology to Mechanism: Cryo-Electron Microscopy Insights into Lipid Nanoparticles for RNA Delivery.ACS nano · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Modular lipid nanoparticles (LNPs) are a promising platform to deliver mRNA to various tissues and cells. Optimization of LNPs for hepatic and extrahepatic tissues often involves substitution of helper lipids or addition of novel lipids not found in conventional four-component LNPs. Among the lipids that comprise LNPs, the functional contributions of phospholipids (PLs) in selective organ targeting (SORT) LNPs remain poorly understood. In this study, we systematically evaluate the roles of PLs within SORT LNPs. Our results demonstrate that PL enrichment enhances cellular transfection efficiency by increasing membrane fusion and endosomal escape. In vivo, we observe that PL-containing SORT LNPs significantly increase protein expression following intramuscular administration in mice, whereas moderate PL inclusion is optimal for intravenous delivery. Cryo-electron microscopy reveals that PL modulation induces distinct morphological rearrangements in LNP structure, which may influence the selective adsorption of plasma proteins, an essential factor in endogenous targeting mechanisms. These findings highlight the fundamental role of PLs in supporting intracellular delivery and guiding organ-specific biodistribution through protein corona formation. A deeper understanding of the structural and functional impact of lipid components, especially PLs, will be crucial for the rational design of next-generation mRNA delivery systems with improved efficacy and precision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.